AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, Los Angeles
Los Angeles, California, United States
Tim Clughsey, MDRecruiting - Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Jeffrey Raizer, MDRecruiting - Henry Ford Health Systems
Detroit, Michigan, United States
Tom Mikkelsen, MDRecruiting - Duke University Medical Center
Durham, North Carolina, United States
David Reardon, MDRecruiting - Baylor Research Institute
Dallas, Texas, United States
Karen Fink, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2006
- Primary completion
- —
- Completion
- —
- Last update posted
- 30 May 2007
- Registered enrollment
- 60
- Registry id
- NCT00394628
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.